Search

Your search keyword '"Voumvourakis, Konstantinos"' showing total 538 results

Search Constraints

Start Over You searched for: Author "Voumvourakis, Konstantinos" Remove constraint Author: "Voumvourakis, Konstantinos"
538 results on '"Voumvourakis, Konstantinos"'

Search Results

2. Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease

7. The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis

10. Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders

11. Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review and Meta-analysis

14. Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy

16. Validation of the transcranial Doppler rescue criteria for mechanical thrombectomy.

20. Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease

22. Duration of paroxysmal atrial fibrillation in cryptogenic stroke is not associated with stroke severity and early outcomes

23. Blood Pressure Variability in Acute Stroke: A Narrative Review.

25. Clinical Characteristics, Neuroimaging Markers, and Outcomes in Patients with Cerebral Amyloid Angiopathy: A Prospective Cohort Study

26. Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination

27. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease

28. The Dynamic Relationship between the Glymphatic System, Aging, Memory, and Sleep

33. Factors associated with the presence of postoperative headache in elective surgery patients: a prospective single center cohort study

40. Cerebral Amyloid Angiopathy—Related Inflammation: A Single-Center Experience and a Literature Review

44. Plasma P-Tau181 for the Discrimination of Alzheimer’s Disease from Other Primary Dementing and/or Movement Disorders

45. Routine clinical measurements effective for the evaluation of the impact of multiple sclerosis on vision-related quality of life early in the disease course?

46. Plasma Phospho-Tau-181 as a Diagnostic Aid in Alzheimer’s Disease

47. Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort

48. Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies

49. Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease: Review and Meta-Analysis

50. Guillain-Barré syndrome and fulminant encephalomyelitis following Ad26.COV2.S vaccination: double jeopardy

Catalog

Books, media, physical & digital resources